Impact of extended panel of genes for germline cancer testing

被引：0
|
作者：
Dawood, S. [1 ]
Wasfy, M. [2 ]
Khoury, R. [2 ]
机构：
[1] Mediclin City Hosp, Dept Oncol, Dubai, U Arab Emirates
[2] IPS Genomix, Dept Med, Beirut, Lebanon
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72P
引用
收藏
页码：S208 / S208
页数：1
相关论文
共 50 条
  • [41] Germline multigene panel testing in colorectal cancer: Precision therapy and clinical management implications.
    Esplin, Edward D.
    Yang, Shan
    Michalski, Scott T.
    Alvarez, Daniel Esteban Pineda
    Lincoln, Stephen E.
    Nussbaum, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [42] Implementation of the Was It Worth It scale to measure perception of large panel germline genetic testing in cancer patients
    Kunze, Katie
    Golafshar, Michael
    Samadder, N. Jewel
    Azevedo, Cindy
    Riegert-Johnson, Douglas
    Boardman, Lisa
    Rhodes, Deborah
    Wick, Myra
    Okuno, Scott
    Stewart, Keith
    Dueck, Amylou
    QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S53 - S54
  • [43] Impact of hereditary multigene panel testing for cancer survivors.
    Kapoor, Nimmi S.
    Swisher, Jennifer
    McFarland, Rachel E.
    Patrick, Mychael
    Curcio, Lisa D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (03)
  • [44] Germline alterations in cancer susceptibility genes in women with high-risk bladder cancer: Implications for germline testing and clinical management.
    Truong, Hong
    Sheikh, Rania
    Khurram, Aliya
    Kemel, Yelena
    Lenis, Andrew Thomas
    Reisz, Peter
    Joseph, Vijai
    Goh, Alvin
    Cha, Eugene K.
    Donahue, Timothy F.
    Coleman, Jonathan
    Pietzak, Eugene J.
    Bochner, Bernard H.
    Offit, Kenneth
    Carlo, Maria Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [45] Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world.
    Cheo, Seng Wee
    Ong, Pei-Yi
    Ow, Samuel Guan Wei
    Chan, Gloria Hui Jia
    Tan, David Shao Peng
    Lim, Yi Wan
    Kong, Hwai L.
    Wong, Andrea
    Lim, Siew Eng
    Walsh, Robert John
    Wong, Alvin S. C.
    Low, Jeffrey
    Ngoi, Natalie Yl
    Lim, Joline Si Jing
    Lee, Soo-Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [46] Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing
    Llorin, Hannah
    Graf, Madeline
    Chun, Nicolette
    Ford, James
    CANCER GENETICS, 2022, 268 : 22 - 27
  • [47] Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes
    Wang, Jiayu
    Li, Weiwei
    Shi, Yujian
    Huang, Yan
    Sun, Tao
    Tang, Lili
    Lu, Qing
    Lei, Qiumo
    Liao, Ning
    Jin, Feng
    Li, Hui
    Huang, Tao
    Qian, Jun
    Pang, Danmei
    Wang, Shusen
    Fan, Peizhi
    Wu, Xinhong
    Lin, Ying
    Qin, Haiyan
    Xu, Binghe
    CANCER MEDICINE, 2019, 8 (05): : 2074 - 2084
  • [48] A Personal History of Pancreatic Cancer and Another Lynch-Related Cancer: A New Indication for Germline Genetic Panel Testing
    Dudley, B.
    Monzon, F.
    Singhi, A.
    Lincoln, S.
    Bahary, N.
    Brand, R.
    PANCREAS, 2015, 44 (08) : 1370 - 1371
  • [49] A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection
    Carolina Velázquez
    Enrique Lastra
    Francisco Avila Cobos
    Luis Abella
    Virginia de la Cruz
    Blanca Ascensión Hernando
    Lara Hernández
    Noemí Martínez
    Mar Infante
    Mercedes Durán
    Journal of Translational Medicine, 18
  • [50] Concordance of germline multigene panel testing with prior microsatellite instability and immunohistochemistry analyses in endometrial cancer patients
    Jasperson, K.
    Espenschied, C. R.
    Hampel, H.
    Reineke, P.
    Pesaran, T.
    Speare, V.
    Profato, J.
    Frayling, I. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 38 - 39
12345